The presence of distant tumor metastases signifies an elevated tumor burden and systemic disease progression; metastatic cells secrete procoagulant agents (e.g., tissue factor, cytokines) that systemically activate coagulation pathways, markedly intensifying hypercoagulability. This evidence concerns the gene F3 and neoplasm.